Perrigo Company plc Defined Benefit Plan, Funded (Unfunded) Status of Plan
Perrigo Company plc (PRGO) had Defined Benefit Plan, Funded (Unfunded) Status of Plan of -$20.70 million as of 2016-12-31, per its 10-K filed 2017-05-22.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan
us-gaap:DefinedBenefitPlanFundedStatusOfPlan · last filed 2017-05-22
- 2016-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$20.70M.
- 2015-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$8.30M; Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed -$100.00K.
- 2015-06-27: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$7.00M.
- 2014-06-28: Defined Benefit Plan, Funded (Unfunded) Status of Plan $10.60M.
| Period end | Defined Benefit Plan, Funded (Unfunded) Status of Plan | Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed |
|---|---|---|
| 2016-12-31 | -$20.70M 10-K · filed 2017-05-22 | |
| 2015-12-31 | -$8.30M 10-K · filed 2017-05-22 | -$100.00K 10-KT · filed 2016-02-25 |
| 2015-06-27 | -$7.00M 10-KT · filed 2016-02-25 | |
| 2014-06-28 | $10.60M 10-K · filed 2014-08-14 | |
| 2014-03-29 | $22.70M 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $22.70M 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |